HomeCompareNEWR vs MRK

NEWR vs MRK: Dividend Comparison 2026

NEWR yields 2.30% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.7K in total portfolio value
10 years
NEWR
NEWR
● Live price
2.30%
Share price
$86.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.1K
Annual income
$266.72
Full NEWR calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NEWR vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEWRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEWR + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEWR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEWR
Annual income on $10K today (after 15% tax)
$195.42/yr
After 10yr DRIP, annual income (after tax)
$226.71/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,101.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEWR + MRK for your $10,000?

NEWR: 50%MRK: 50%
100% MRK50/50100% NEWR
Portfolio after 10yr
$39.9K
Annual income
$5,032.43/yr
Blended yield
12.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NEWR
Analyst Ratings
6
Buy
21
Hold
2
Sell
Consensus: Hold
Price Target
$86.38
-0.7% upside vs current
Range: $55.00 — $150.00
Altman Z
7.2
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEWR buys
0
MRK buys
0
No recent congressional trades found for NEWR or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEWRMRK
Forward yield2.30%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$23.1K$56.8K
Annual income after 10y$266.72$9,798.13
Total dividends collected$2.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$86.38$128.54

Year-by-year: NEWR vs MRK ($10,000, DRIP)

YearNEWR PortfolioNEWR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,930$229.91$11,206$366.19$276.00MRK
2$11,930$234.85$12,650$502.35$720.00MRK
3$13,005$239.57$14,407$694.19$1.4KMRK
4$14,159$244.06$16,585$967.82$2.4KMRK
5$15,398$248.34$19,342$1,363.89$3.9KMRK
6$16,729$252.42$22,913$1,947.19$6.2KMRK
7$18,156$256.28$27,662$2,823.89$9.5KMRK
8$19,687$259.95$34,159$4,173.35$14.5KMRK
9$21,328$263.43$43,337$6,308.80$22.0KMRK
10$23,088$266.72$56,776$9,798.13$33.7KMRK

NEWR vs MRK: Complete Analysis 2026

NEWRStock

New Relic, Inc., a software-as-a-service company, delivers a software platform for customers to collect telemetry data and derive insights from that data in a unified front-end application. It offers a suite of products on its open and extensible cloud-based platform, which enables users to collect, store, and analyze telemetry data. The company's platform also provides New Relic Instant Observability, an open-source ecosystem of quickstarts that delivers pre-built integrations, dashboards, and alerts for approximately 450 technologies and frameworks; and supports custom app development through common open-source frameworks, a library of existing applications, and a development environment. It sells its products through direct sales organizations, and online and offline sales in the United States and internationally. New Relic, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Full NEWR Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NEWR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEWR vs SCHDNEWR vs JEPINEWR vs ONEWR vs KONEWR vs MAINNEWR vs JNJNEWR vs ABBVNEWR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.